Anurag Relan

2PUBLICATIONS
18CO-AUTHORS
Pharmaceutical delivery technologiesAutoimmunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Oct 14, 2026
Open-label extension study of leniolisib in activated PI3Kδ syndrome: Long-term efficacy and safety.

|Nov 18, 2022
A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome.

V Koneti Rao, Sharon Webster, Anna Šedivá

Pageof 1

Frequent Collaborators

2 joint publications

V Koneti Rao

2 joint publications

Anna Šedivá

2 joint publications

Julia Körholz

2 joint publications

Yulia Rodina